ext 12 months — We foresee multiple catalysts in next twelve months, including NDA filing for Tamsulosin, VERU-944 Phase 2 initiation and data, and VERU-111 IND filing and data. Solifenacin DRG and TadalafillFinasteride combo capsules NDA filing is expected in 2019. Equity Research Kmr I' ll' PhD Dir or